Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Imiquimod
Latest prescription information about Imiquimod. Learn how to pronounce the drug’s name, its indications, dosage, how to take, when to take, when not to take, side effects, special precautions, its storage instructions and warnings if any when taken during pregnancy. Also listed are the International and Indian trade name(s) of the drug and its price list.
|
Generic Name : Imiquimod
Pronunciation : im-I-kwi-mod
Therapeutic Classification : Miscellaneous Dermatologicals
ICD Code : Y56.9
Trade Name(s): India- Imiquad, Nilwart. International- Zyclara. Why it is prescribed (Indications) : This medication is an immune response modifier, prescribed for certain types of skin growths (actinic keratoses) or skin cancer (superficial basal cell carcinoma). When it is not to be taken (Contraindications): Hypersensitivity.
Dosage & When it is to be taken : Topical: Apply a thin layer of this cream 2 times per week for 16 weeks. How it should be taken : It comes as a cream to apply topically over the affected area as directed by your physician. Warnings and Precautions : * Caution should be exercised in patients with history of poor immune system, autoimmune disorder, human papilloma virus (HPV) infection, other types of skin cancer, broken, damaged or inflamed skin, any allergy, who are taking other medications, children, during pregnancy and breastfeeding. * It may cause dizziness, do not drive a car or operate machinery while taking this medication. * For external use only; avoid contact with vagina, eyes, nose, mouth, lips. * Avoid exposure to sunlight. Side Effects : Application site reaction, upper respiratory tract infection, headache, skin cancer, diarrhea, eczema, back pain, fatigue, abnormal heart rhythm, viral infection, dizziness, vomiting, urinary tract infection, fever, rigors and hair loss. *Avoid excess dosage. Storage Conditions : Store it at 4 - 25°C. |
 Comment & Contribute
| ||
Browse the Drugs alphabetically
Reference
- Food and Drug Administration (FDA)
- National Institutes of Health (NIH)
- PubMed
- CIMS
- Indian Pharma Reference Guide 2012
Drugs Index
Price List 
Pharma Links
Recently added Drugs
Quick Links
Ask an Expert
